Lidocaine concentrations in 49 endotracheobronchial aspirates ranged from 12,580 to 23 jtg/ml. The aspirates taken from the larger airway contained higher concentrations of lidocaine than those obtained from the smaller airway. Of the aspirates collected before 10 minutes after the final lidocaine administration, the lidocaine concentration of 7 (24.1%) of 29 specimens was greater than 3,000jug/ml, however, in the aspirates collected after 10 minutes, only 1 (5%) of 20 specimens showed a concentration greater than 3,000 jig/ml. Using the dilution technique method (DTM) of lidocaine in the fiberscope (FS) suction channel, gradual injection of a 2 ml saline solution into the suction channel and removal of the saline solution in the suction channel were performed immediately with a suction machine; the statistically significant differences (p <0.001) between lidocaine concentrations in the specimens before and after the DTM procedure were determined. 
Intro duction
The quantitative and qualitative antimicrobial effects of lidocaine solution in connection with bronchoscopy were reported by Erlich in 1961 (1) . Other techniques to prevent or reduce this side effect during flexible fiberoptic broncho scopy (FFB) were also reported by Wanner et al in 1973 (2) and others. Here, we present further investigation of the varying levels of lidocaine concentration in tracheobronchial lumens during FFB, to facilitate better collection of microbiological specimens. Lidocaine concentrations in the expectorated sputa, urine and blood samples were measured immediately after FFB.
Materials and Methods
A nesthesia Two percent lidocaine solution was used for topical (surface) anesthesia for flexible fiberoptic bronchoscopy (FFB) by the typical technique. The pharyngo-laryngeal spaces were anesthetized, either by a Jakson type spray device or a motor driven spray machine. An ultrasonic nebulizer for airway anesthesia was not used in this study. Lidocaine solution was instilled into the glottic and subglottic spaces, via the fiberscope (FS) channel under obser vation with the FS, or by lidocaine instillation using an in jector with the help of indirect larygoscopy, depending upon the condition of the patient. The lidocaine dose for the upper airway anesthesia of each patient was approximately 5 to 10 ml. Additional solution of about 1.0 to 2.0 ml was instilled separately into several tracheobronchial lumens via the FS channel. Lidocaine, in doses ranging widely from 9 to 30 ml, was administrated to all 25 patients. Of these, the age of the males ranged from 34 to 81, and females from 27 to 84. To prevent overuse of lidocaine solution during FFB in accordance with the individual patient's condition, 0.5 mg of atropine sulfate (Atropine) and/or, a 25 mg of hydroxy zine (Atarax P) and/or, 25 mg of hydroxyzine hydrochloride (Sosegon) were injected intramuscularly, about 30 minutes prior to beginning FFB. Additional injections of the above two or three medicines are performed during FFB, due to hyper secretion in the airways and psychological upset or pharyngo-laryngeal pain during FFB. To avoid toxic reac tions during FFB, the maximum lidocaine dosage which is thought to be around 400 mg (20 ml of two percent lido caine), did not exceed 600 mg.
Material sampling Transoral insertion of an endotracheal (ET) tube method was used for simple material sampling from the airway. When necessary, alternate use of a different FS, to clear away mucus or blood on the surface of the FS, including the objective lens, was applied to ensure a better transfiberscopic view and oxygen inhalation during FFB. The diameter of the ET tube, selected according to the gender of the patient, was disinfected or sterilized before FFB, then a sterilized or disinfected FS was inserted into the ET tube, and the ET tube was attached to the most proximal (flexible) part of the FS, with adhesive tape. After intubation of the FS into the trachea, the adhesive tape was removed. The ET tube was inserted gently and cautiously into the trachea, with a twisting action as a guide to the FS. The insertion of the ET tube continued until the tip reached the center of the trachea. The FS was then withdrawn and the ET tube was fixed at that position with adhesive tape attached to the patient's perioral area. The total of 112 endotracheobronchial specimens in cluded 49 secretion aspirates, 20 washing aspirates from the tracheobronchial lumens, one bronchoalveolar lavage fluid (BALF) and four brushing specimens taken from peripheral airways during FFB. After brushing within the lesion, to obtain brush specimens, the brush was extracted until the proximal part of the brush reached about 1 cm from the suction channel exit of the FS, then the FS and brush were together withdrawn carefully from the airway. Only the brush part was soaked and mixed well with 1 ml of saline solution in a test tube. The effects of the dilution technique method (DTM) in four in vitro and 14 in vivo specimens were examined, following serial procedures (Fig. 1) . DTM in vitro study Procedure A. (contamination of lidocaine in the FS suction channel): 1 ml of 2% lidocaine solution was instilled into the suction channel of the FS, via a proximal suction channel exit, and after a short interval, disposal of the lido caine solution in the suction channel was achieved. Pro cedure B. (dilution of lidocaine solution in the suction channel): gradual instillation of 2 ml saline solution was administrated into the suction channel of the FS, and im mediately after this procedure, suction in the channel content and its disposal, was carried out. Procedure C. (suction for sampling): after procedure B, suction of 2 ml of saline solution in a test tube was aspirated via suction channel of the FS, and lidocaine concentration in the specimen was measured by gas chromatography (Fig. 1,  top) . DTM in vivo study Procedure A. (contamination of lidocaine in the suction channel): this is thought to have occurred spontaneously, during FFB without any manipulative procedure. Procedure B. (dilution of lidocaine in the suction channel): the same procedure as in procedure B of the in vitro study was carried out. Procedure C. (suction for sampling): this procedure was performed in the same wasy as procedure C of the in vitro study. However, the sample was taken from the airway of the patient during FFB, rather than from the saline solution in the test tube (Fig. 1, bottom) . The handling of the FS used for this in vitro study was nearly the same as a real FFB. Lidocaine concentrations in the nine blood and urine specimens each and two sputa specimens were measured immediately after FFB. All nine patients for the precise lidocaine contamination examination of the urine specimen, were asked to completely empty their bladder, just before the beginning of local anesthesia by lidocaine solution.
L idocaine concentration A total of 1 12 specimens were examined as already men tioned earlier. Four in vitro DTM specimens and 14 in vivo DTM specimens, nine each of blood and urine, and two sputa specimens were also examined. A Machida FBS 6TL was used for this study. In each experiment, a lidocaine free and clean suction channel FS was prepared for endo tracheobronchial aspirate collection. However, for the DTM specimens, the same FS was used for both routine FFB sampling and the aspirate collection via the FS suction channel after the DTM procedure. Lidocaine concentration in the specimens were measured by gas chromatography using a Hewlett-Packard 5890 A gas chromatograph with a flame ionization detector. Results Among the 49 secretion aspirates, 5 (10.2%) contained more than 8,000^g/ml, and another 3 (6. 1 %) more than 3,000,«g/ml of lidocaine. These 8 (16.3%) specimens were obtained from the trachea, bilateral main and lobar bronchi.
1) Lidocaine concentrations in secretion aspirates via FS channel (
centrations in washing aspirates and one BALF via FS channel (Table 3 and Fig. 2 ) Lidocaine concentrations of 20 washing aspirates and one BALF were classified according to the saline solution doses administrated. As shown in Table 3 and Fig. 2 , the 2 ml or more saline solution dosage groups showed a better effect of lidocaine dilution in the FS channel, compared to the 1 ml saline solution dosage group. Three specimens con The three specimens containing 9,280, 4,400 and 4,100 tug/ml of lidocaine, all belonged to the group washed with 1 ml saline solution doses. Con sidering saline solution doses and the resultant lidocaine concentrations in bronchoscopic washing aspirates, more than 2 ml saline solution group showed a better effect of lidocaine dilution in the fiberscope suction chann aefDenotes BALF sample;
10,000 9,00(H 8,000
7,000-1 6,000-| 5,000 4,000 3,000-1 2,000-| taining 9,280, 4,400 and 4,100 /ig/ml of lidocaine all be longed to the group which had been washed with 1 ml saline solution dosage. Specimens washed with more than 2 ml saline solution showed a lidocaine concentration of 2,900 g/ml or somewhat less and the variance of lidocaine con centrations in this group was also smaller than that in the 1 ml saline solution dosage group. 4) Lidocaine concentrations in brushing specimens via FS channel (Table 4) Lidocaine concentrations in all four brushing specimens were up to 524 ^g/ml or less. The minimum concentration in this group was 4^g/ml. The concentrations in the brush specimens were much lower than those in the aspirate specimens. 5) Lidocaine concentrations in secretion aspirates via FS channel by time interval (Table 5) The collected secretion aspirates were divided into two groups. The early aspirates (29) were collected within 10 minutes of the final lidocaine administration, the late aspirates (20) were collected after 10 minutes. Regarding the lidocaine concentrations, five (17.2%) of Table 4 .
Lidocaine Concentrations in Brushing Specimens Via Fiberscope Suction Channel
Patient(n = 4) Lidocaine concentration(«g/ml) All brushing specimens were soaked and stirred well with a brush in a test tube containing 1 ml saline solution. Lidocaine concentrations in these brush specimens were much lower than those in the secretion aspirate specimens. 6) Effect oflidocaine DTM in a FS channel (in vitro study) ( Fig. 1 top and Table 6 ) Lidocaine concentrations in four in vitro specimens, after DTM procedure, showed marked dilution. Almost 98% of the remaining lidocaine solutions in the FS channel of both specimens A and B were washed out by this procedure, as shown in Table 6 . These post-DTM lidocaine concentrations Sample A: 2% lidocaine injection into the FS channel was 1 ml. Sample B: 2% lidocaine injection into the FS channel was 1.5 ml. DTM is the abbreviation for dilution technique method and denotes that before sampling, the gradual injection of 1 ml saline solution into the FS channel, and disposal was carried out immediately with a suctio machine. Ratio of dilution = Lidocaine concentration in the aspirate before DTM -after DTM before DTM ( ) Among all 29 early aspirates, 5 (17.2%) contained more than 8,000 ^g/ml, and another 2 (6.9%) more than 3,000^g/ml of lidocaine. However, among the 20 late aspirates, only 1 (5%) specimen contained more than 5,000/ig/ml. This specimen was obtained 16 minutes after the final lidocaine administration. "Time after final lidocaine administration.
Lidocaine dosages in the airway of the patients ranged from 3.5 to 15 ml. Statistical analysis before and after DTM proved significant differences between mean values (p<0.001). Ratio of dilution = Lidocaine concentration in the aspirate before DTM -after DTM before DTM à"(%) of the remaining lidocaine in the FS suction channel was washed out by this procedure, as shown in Table 7 . Lido caine concentrations in the in vivo study specimens were more varied than those in the in vitro study. However, statistical analysis of these clinical results proved significant differences between both mean values (p <0.001). 8) Lidocaine concentrations in the specimens immediately after FFB (Table 8 [ig/ml in sputum, 1.39 /ig/ml in blood and 8.6 ^g/ml in urine specimens. Discussion
Lidocaine solution is one of the safest and most widely used anesthetics for bronchoscopic examination (3) (4) (5) . However, it has several unfavorable side effects, such as cardiac and central nerve system toxicity (6-15), broncho constriction in asthmatic patients (16) , immunocompetent cell population changes in the bronchoalveolar lavage fluid (17) and antimicrobial action (1, 8-23 ).
These side effects, particularly the antimicrobial effect, occur proportionally to the density and time of exposure to the lidocaine solution in the tracheobronchoalveolar lumens, and are dependent upon the capabilities of both lidocaine absorption through the mucus membrane and the abilities of mucociliary transport (MCT) function of the patients.
From the viewpoint of transbronchoscopic microbiology, contaminations of both bacterial flora and lidocaine may occur within the endobronchial secretions during broncho scopy are unavoidable problems (24). Usually, normal bacterial floras in the samples obtained are differentiated from the causal microorganisms, in relation to the clinical manifestation. And also, the causal microorganisms can be identified by means of transbronchial selective culture from the lesion with a significant growth of the microorganisms at lOVml colony forming unit (25-27).
In reports describing the obtaining of transbroncho scopical specimens from localized lesions without normal bacterial floral contamination, the use of various devices were discussed (2, (28) (29) (30) (31) . In obtaining microbiological specimens from the localized bronchopulmonary lesions by a routine FS, the following important point must be con sidered; exact sampling from the lesion while excluding significant microbiological and lidocaine contamination during the procedure is very important. (22), the concentrations of lidocaine having a significant antimicrobial effect are thought to range from 3 ,000 ftg/ml (0.3% lidocaine solution) to 5,000 ^g/ml; and bacteriocidal effect, around 8,000 to 10,000 /^g/ml or more. Therefore, the lidocaine concentration in the transbronchoscopic microbiological samples might be less than 3,000 ^g/ml. To explain why the aspirates obtained from the larger airways contained more lidocaine than those obtained from the smaller airways, the following reasons were considered: Most of the aspirates containing high concentrations of lidocaine in this study belonged to the early aspirates group, and therefore lidocaine solution might have remained in the suction channel, a large portion of the lidocaine instilled into the airways was not absorbed, and was still moving toward the larger airway from the smaller peripheral airway by MCT function. which contained bacteriocidal effect of lidocaine density and another two samples which contained bacteriostatic effect of lidocaine density, all belonged to early aspirates group. However, one (5 %) sample which contained an intermediate effect between bacteriocidal and bacteriostatic lidocaine densities belonged to the late aspirates group. Thus, based on the lidocaine concentrations in the aspirates obtained through the FS suction channel, the time interval from the final lidocaine administration is thought to be a more important factor than the diameter of the airways. Con sequently, microbiological examination of samples through the FS channel, was possible with the late aspirates. This is because with an interval of 10 minutes or more, spontaneous lidocaine drainage from the FS suction channel to the airway may occur, and the suction of mucus from the airway, to ensure a clear view through the FS, also decreases the remaining lidocaine in the FS suction channel. Lidocaine concentrations in all four brushing specimens , which were soaked and mixed with 1 ml saline solution in a test tube contained 102^g/ml or less of lidocaine. This was a favorable result from the viewpoint of lidocaine contamination; however, microbiological contamination was nearly consistently unfavorable by this procedure. In general, therefore, this procedure is not recommendable for transfiberscopic microbiology, except with the use of an uncontaminated sheathed brush or other protected devices for microbiology (26-31).
The absorption of administrated lidocaine solution in the airway was fairly rapid, and at around 15 to 45 minutes after administration, blood levels continued to increase until maximum concentration; from 60 to 120 minutes, the lidocaine concentration in blood gradually decreased (32-38).
In the present study, most of the specimens containing a lidocaine concentration of 103 to 104 ^g/ml belonged to the early aspirates group, and with timing of FFB, the lidocaine concentrations gradually decreased to 10 to 102 ^g/ml. Nearly the same results were reported by Strange et al (39). These data were indirectly affirmative for safety sampling of late aspirates under sufficient local anesthetic condition. The mean duration of local anesthetic effect of 4% lido caine is 15.2 minutes (3, 4) . In the present study, a longer duration of local anesthetic effect of 2% lidocaine of between 30 to 58 minutes was obtained. These data show that, it is really possible to obtain endotracheobronchial late aspirates for a microbiological examination under satis factory anesthetic condition. However, lidocaine contamina tion in the aspirates occurs, almost always during FFB (24). Therefore, it is very important that the microbiological specimens obtained transbronchoscopically are stained and cultured, as quickly as possible (22) . To obtain a better microbiological specimen, it is im portant that, frequent and effective suctioning through the suction channel of the FS during FFB, and DTM procedures immediately before sampling is one of the most simple and reliable procedures for decreasing the remaining lidocaine solution in the suction channel of the FS (40).
